Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 46Neoplasms 19Breast Neoplasms 9Head and Neck Neoplasms 8Squamous Cell Carcinoma of Head and Neck 6Lung Neoplasms 6Stomach Neoplasms 3Neoplasm Metastasis 3Colorectal Neoplasms 3Glioblastoma 2Carcinoma, Squamous Cell 2Adenocarcinoma 2Urologic Neoplasms 1Unilateral HER2 Positive Breast Cancer 1Thoracic Neoplasms 1Squamous Non-small Cell Lung Cancer 1Squamous Cell Cancers of the Head and Neck 1Solid Tumors 1Rhabdomyosarcoma 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Prostatic Neoplasms 1Pleural Neoplasms 1Pleural Effusion, Malignant 1Pleural Effusion 1Pleural Diseases 1Pancreatic Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors 1Neoplasms, Squamous Cell 1

Interventions

Temozolomide 94Radiotherapy 59Bevacizumab 59Radiosurgery 41Carboplatin 27Irinotecan 26Magnetic Resonance Spectroscopy 25Surgical Procedures, Operative 23Etoposide 22Carmustine 20Filgrastim 18Erlotinib Hydrochloride 17Cyclophosphamide 16Cisplatin 16Vincristine 15Lomustine 15Lapatinib 15Sorafenib 13Radiation 13Trastuzumab 12Nivolumab 12Imatinib Mesylate 12Thalidomide 11Surveys and Questionnaires 11Granulocyte Colony-Stimulating Factor 11Radiotherapy, Intensity-Modulated 10Aminolevulinic Acid 10temsirolimus 9Topotecan 9Thiotepa 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Brain Neoplasms × Afatinib × Clear all
NCT02423525 2022-03-10

Safety Study of Afatinib for Brain Cancer

Saint John's Cancer Institute

Phase 1 Completed
24 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Meningioma, Oligodendroglioma, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡